Testosterone, thrombophilia, thrombosis

Translational Research

Volumn 165, Issue 5, 2015, Pages 537-548

  Freedman, Joel ^a   Glueck, Charles J ^a   Prince, Marloe ^a   Riaz, Rashid ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; CHORIONIC GONADOTROPIN; ESTRADIOL; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RIVAROXABAN; TESTOSTERONE; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANDROGEN THERAPY; ANTICOAGULANT THERAPY; ARTICLE; BONE NECROSIS; CENTRAL RETINA VEIN OCCLUSION; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ESTRADIOL BLOOD LEVEL; FAMILY HISTORY; FEMALE; HUMAN; HYPOGONADISM; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; COMPLICATION; PULMONARY EMBOLISM; RISK FACTOR; TRANSLATIONAL RESEARCH; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; TESTOSTERONE; THROMBOPHILIA; THROMBOSIS; TRANSLATIONAL MEDICAL RESEARCH; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84927911634     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.12.003     Document Type: Article

References (67)

1. J. Baillargeon, R.J. Urban, K.J. Ottenbacher, K.S. Pierson, and J.S. Goodwin Trends in androgen prescribing in the United States, 2001 to 2011 JAMA Intern Med 173 2013 1465 1466
2. C.J. Glueck, C. Richardson-Royer, and R. Schultz Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study Clin Appl Thromb Hemost 20 2014 244 249
3. C.J. Glueck, D. Bowe, A. Valdez, and P. Wang Thrombosis in three postmenopausal women receiving testosterone therapy for low libido Womens Health (Lond Engl) 9 2013 405 410
4. C.J. Glueck, N. Goldenberg, and S. Budhani Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia Transl Res 158 2011 225 234
5. C.J. Glueck, C. Richardson-Royer, and R. Schultz Testosterone, thrombophilia, and thrombosis Clin Appl Thromb Hemost 20 2014 22 30
6. R.S. Pandit, and C.J. Glueck Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws Blood Coagul Fibrinolysis 25 2014 286 288
7. C.J. Glueck, and P. Wang Testosterone therapy, thrombosis, thrombophilia, cardiovascular events Metabolism 63 2014 989 994
8. S. Basaria, A.D. Coviello, and T.G. Travison Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
9. R. Vigen, C.I. O'Donnell, and A.E. Baron Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels JAMA 310 2013 1829 1836
10. W.D. Finkle, S. Greenland, and G.K. Ridgeway Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men PLoS One 9 2014 e8595
11. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
12. C. Valdiviezo, S. Lawson, and P. Ouyang An update on menopausal hormone replacement therapy in women and cardiovascular disease Curr Opin Endocrinol Diabetes Obes 20 2013 148 155
13. B.D. Anawalt Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal J Clin Endocrinol Metab 95 2010 2614 2617
14. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
15. A.B. Araujo, G.R. Esche, and V. Kupelian Prevalence of symptomatic androgen deficiency in men J Clin Endocrinol Metab 92 2007 4241 4247
16. J.B. Layton, D. Li, and C.R. Meier Testosterone lab testing and initiation in the United Kingdom and the United States, 2000-2011 J Clin Endocrinol Metab 99 2014 835 842
17. H.A. Feldman, C. Longcope, and C.A. Derby Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study J Clin Endocrinol Metab 87 2002 589 598
18. F.C. Wu, A. Tajar, and S.R. Pye Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study J Clin Endocrinol Metab 93 2008 2737 2745
19. J. Svartberg, and R. Jorde Endogenous testosterone levels and smoking in men. The fifth Tromso study Int J Androl 30 2007 137 143
20. W. Wang, X. Yang, and J. Liang Cigarette smoking has a positive and independent effect on testosterone levels Hormones (Athens) 12 2013 567 577
21. S. Lazarou, L. Reyes-Vallejo, and A. Morgentaler Wide variability in laboratory reference values for serum testosterone J Sex Med 3 2006 1085 1089
22. L.M. McShane, J.F. Dorgan, S. Greenhut, and J.J. Damato Reliability and validity of serum sex hormone measurements Cancer Epidemiol Biomarkers Prev 5 1996 923 928
23. Y.M. Yun, J.C. Botelho, and D.W. Chandler Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the Partnership for the Accurate Testing of Hormones Clin Chem 58 2012 1703 1710
24. J.S. Finkelstein, E.W. Yu, and S.A. Burnett-Bowie Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med 369 2013 2457
25. C.J. Glueck, R.A. Freiberg, and P. Wang Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head Clin Orthop Relat Res 466 2008 1034 1040
26. C.J. Glueck, R.A. Freiberg, and G. Boriel The role of the factor V Leiden mutation in osteonecrosis of the hip Clin Appl Thromb Hemost 19 2013 499 503
27. M. Spitzer, G. Huang, S. Basaria, T.G. Travison, and S. Bhasin Risks and benefits of testosterone therapy in older men Nat Rev Endocrinol 9 2013 414 424
28. M.M. Fernandez-Balsells, M.H. Murad, and M. Lane Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 2010 2560 2575
29. O.K. Baskurt, and H.J. Meiselman Iatrogenic hyperviscosity and thrombosis Semin Thromb Hemost 38 2012 854 864
30. E.I. Peerschke, R.T. Silver, B.B. Weksler, W. Yin, B. Bernhardt, and D. Varon Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis Am J Clin Pathol 127 2007 422 428
31. A.K. Death, K.C. McGrath, and M.A. Sader Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway Endocrinology 145 2004 1889 1897
32. B. Pamukcu, G.Y. Lip, A. Devitt, H. Griffiths, and E. Shantsila The role of monocytes in atherosclerotic coronary artery disease Ann Med 42 2010 394 403
33. R.S. Tan, K.R. Cook, and W.G. Reilly High estrogen in men after injectable testosterone therapy: the low t experience Am J Mens Health 2014 pii: 1557988314539000 [Epub ahead of print]
34. E. Hoibraaten, E. Qvigstad, T.O. Anderson, M.C. Mowinckel, and P.M. Sandset The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial Thromb Haemost 85 2001 775 881
35. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 336 2008 1227 1231
36. M. Sinnesael, S. Boonen, F. Claessens, E. Gielen, and D. Vanderschueren Testosterone and the male skeleton: a dual mode of action J Osteoporos 2011 2011 240328
37. A. Eisenberger, and C. Westhoff Hormone replacement therapy and venous thromboembolism J Steroid Biochem Mol Biol 142 2014 76 82
38. FDA Testosterone products: FDA/CDER statement-risk of venous blood clots 2014 FDA Medwatch
39. Health Canada. Summary safety review. Testosterone replacement products and cardiovascular risk. 2014.
40. K. Kobberoe Sogaard, M. Schmidt, L. Pedersen, E. Horvath-Puho, and H. Toft Sorensen 30-year mortality after venous thromboembolism: a population-based cohort study Circulation 130 2014 829 836
41. E.D. Kim, L. Crosnoe, N. Bar-Chama, M. Khera, and L.I. Lipshultz The treatment of hypogonadism in men of reproductive age Fertil Steril 99 2013 718 724
42. B. Cosmi, C. Legnani, F. Bernardi, S. Coccheri, and G. Palareti Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study BMJ 322 2001 1024 1025
43. C.M. Schambeck, S. Schwender, I. Haubitz, U.E. Geisen, R.E. Grossmann, and F. Keller Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives? Thromb Haemost 78 1997 1480 1483
44. J. Aznar, A. Vaya, and A. Estelles Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives Haematologica 85 2000 1271 1276
45. M. den Heijer, T. Koster, and H.J. Blom Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 334 1996 759 762
46. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb Haemost 74 1995 1185 1190
47. R.L. Bick Antiphospholipid thrombosis syndromes Clin Appl Thromb Hemost 7 2001 241 258
48. T.P. Greco, M.D. Amos, A.M. Conti-Kelly, J.D. Naranjo, and J.W. Ijdo Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I Lupus 9 2000 33 41
49. GmbH RD. Testosterone II, estradiol II: electrochemiluminescence immunoassay, Reference #s 05200067 160, 03000079 122; 2010:1-5.
50. J. Wang, A.S. Sim, and X.L. Wang Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease Atherosclerosis 197 2008 853 859
51. H. Al-Mondhiry, A. Manni, J. Owen, and R. Gordon Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer Am J Hematol 28 1988 141 145
52. P.W. Kamphuisen, J.C. Eikenboom, and R.M. Bertina Elevated factor VIII levels and the risk of thrombosis Arterioscler Thromb Vasc Biol 21 2001 731 738
53. M. den Heijer Hyperhomocysteinaemia as a risk factor for venous thrombosis: an update of the current evidence Clin Chem Lab Med 41 2003 1404 1407
54. M. den Heijer, H.P. Willems, and H.J. Blom Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial Blood 109 2007 139 144
55. M. Cattaneo Hyperhomocysteinemia and venous thromboembolism Semin Thromb Hemost 32 2006 716 723
56. C.J. Glueck, R.K. Hutchins, J. Jurantee, Z. Khan, and P. Wang Thrombophilia and retinal vascular occlusion Clin Ophthalmol 6 2012 1377 1384
57. T. Gadelha, V. Roldan, and R. Lecumberri Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry Thromb Res 126 2010 283 286
58. P. Ivanov, R. Komsa-Penkova, and K. Kovacheva Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences Lung 186 2008 27 36
59. J.A. Caprini, S. Goldshteyn, C.J. Glase, and K. Hathaway Thrombophilia testing in patients with venous thrombosis Eur J Vasc Endovasc Surg 30 2005 550 555
60. R. Ben Salah, F. Frikha, and N. Kaddour Risk factor for deep venous thrombosis in internal medicine: a retrospective study of 318 cases Ann Cardiol Angeiol (Paris) 63 2014 11 16
61. O. Turan, B. Undar, T. Gunay, and A. Akkoclu Investigation of inherited thrombophilias in patients with pulmonary embolism Blood Coagul Fibrinolysis 24 2013 140 149
62. J.D. Douketis, J.A. Julian, and M.A. Crowther The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study Clin Appl Thromb Hemost 17 2011 E106 E113
63. M.M. Cherrier, A.M. Matsumoto, and J.K. Amory The role of aromatization in testosterone supplementation: effects on cognition in older men Neurology 64 2005 290 296
64. O. Wu, L. Robertson, and S. Twaddle Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis Br J Haematol 131 2005 80 90
65. O. Wu, L. Robertson, and S. Twaddle Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study Health Technol Assess 10 2006 1 110
66. A. Blanco-Molina, and M. Monreal Venous thromboembolism in women taking hormonal contraceptives Expert Rev Cardiovasc Ther 8 2010 211 215
67. V. Beral, E. Banks, and G. Reeves Evidence from randomised trials on the long-term effects of hormone replacement therapy Lancet 360 2002 942 944